Loading…

Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis

Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for develo...

Full description

Saved in:
Bibliographic Details
Published in:Current neuropharmacology 2023-01, Vol.21 (6), p.1319-1328
Main Authors: Ilzarbe, Lidia, Ilzarbe, Daniel, Gutiérrez-Arango, Felipe, Baeza, Inmaculada
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3
container_end_page 1328
container_issue 6
container_start_page 1319
container_title Current neuropharmacology
container_volume 21
creator Ilzarbe, Lidia
Ilzarbe, Daniel
Gutiérrez-Arango, Felipe
Baeza, Inmaculada
description Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents. Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex. Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex. Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant. Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.
doi_str_mv 10.2174/1570159X21666221027143920
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2730319906</sourcerecordid><originalsourceid>FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3</originalsourceid><addsrcrecordid>eNp1Uk2v0zAQjBCI93jwF1C4cQnYTuzEXFBVPqUiEAWJm-U4m8bg2MF2Wnrhxv_GeX1UcODktWZmd1azWfYIoycE19VTTGuEKf9CMGOMEIxIjauSE3Qru8RNTQuGObqd6sQrFuJFdi-ErwgR2pD6bnZRshJRXDaX2c8t_Mhf6L4HD1ZByLXNt-DnMf_gnZEqpv8G9mCukfWgTZeIubRdvuqcgaDAxpA7m69s1FM4qsFFrcKzfJVvjyHCKNM3_wh7DYdr2TuIslhZaY5Bh_vZnV6aAA9u3qvs86uXn9Zvis3712_Xq03RVryKRdMS2vNKVrKlXGFJa8wJa1GdUNWykmCsFFSMKk4p7jDnnNVNw3tVow5YX15lz099p7kdoVtMe2nE5PUo_VE4qcW_iNWD2Lm9wKgkVUl46vD4poN332cIUYw6LW-MtODmIEhdojINRixR-YmqvAvBQ3-eg5FYAhT_DTBpH_5t9Kz8k1gi_DoR2uR0kGNQegnuTBxinMThcBAwe_gmAxhQUSg3CjeBnb1JtY1JK6ZhEjuwHoT0KSMDQodgxXJAYjkgsXdmHiE5XoAZBBNhkjsQOO1Z_gYKNsuR</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2730319906</pqid></control><display><type>article</type><title>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</title><source>PubMed Central</source><creator>Ilzarbe, Lidia ; Ilzarbe, Daniel ; Gutiérrez-Arango, Felipe ; Baeza, Inmaculada</creator><creatorcontrib>Ilzarbe, Lidia ; Ilzarbe, Daniel ; Gutiérrez-Arango, Felipe ; Baeza, Inmaculada</creatorcontrib><description>Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents. Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex. Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex. Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant. Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.</description><identifier>ISSN: 1570-159X</identifier><identifier>EISSN: 1875-6190</identifier><identifier>DOI: 10.2174/1570159X21666221027143920</identifier><identifier>PMID: 36305138</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers</publisher><subject>Adolescent ; Adult ; Antipsychotic Agents - therapeutic use ; Child ; Female ; Humans ; Male ; Medicine, Neurology, Pharmacology, Neuroscience ; Olanzapine ; Prolactin ; Risperidone - therapeutic use ; Sex Characteristics</subject><ispartof>Current neuropharmacology, 2023-01, Vol.21 (6), p.1319-1328</ispartof><rights>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</rights><rights>2023 Bentham Science Publishers 2023 Bentham Science Publishers</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324329/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324329/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36305138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ilzarbe, Lidia</creatorcontrib><creatorcontrib>Ilzarbe, Daniel</creatorcontrib><creatorcontrib>Gutiérrez-Arango, Felipe</creatorcontrib><creatorcontrib>Baeza, Inmaculada</creatorcontrib><title>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</title><title>Current neuropharmacology</title><addtitle>CN</addtitle><description>Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents. Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex. Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex. Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant. Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Child</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine, Neurology, Pharmacology, Neuroscience</subject><subject>Olanzapine</subject><subject>Prolactin</subject><subject>Risperidone - therapeutic use</subject><subject>Sex Characteristics</subject><issn>1570-159X</issn><issn>1875-6190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1Uk2v0zAQjBCI93jwF1C4cQnYTuzEXFBVPqUiEAWJm-U4m8bg2MF2Wnrhxv_GeX1UcODktWZmd1azWfYIoycE19VTTGuEKf9CMGOMEIxIjauSE3Qru8RNTQuGObqd6sQrFuJFdi-ErwgR2pD6bnZRshJRXDaX2c8t_Mhf6L4HD1ZByLXNt-DnMf_gnZEqpv8G9mCukfWgTZeIubRdvuqcgaDAxpA7m69s1FM4qsFFrcKzfJVvjyHCKNM3_wh7DYdr2TuIslhZaY5Bh_vZnV6aAA9u3qvs86uXn9Zvis3712_Xq03RVryKRdMS2vNKVrKlXGFJa8wJa1GdUNWykmCsFFSMKk4p7jDnnNVNw3tVow5YX15lz099p7kdoVtMe2nE5PUo_VE4qcW_iNWD2Lm9wKgkVUl46vD4poN332cIUYw6LW-MtODmIEhdojINRixR-YmqvAvBQ3-eg5FYAhT_DTBpH_5t9Kz8k1gi_DoR2uR0kGNQegnuTBxinMThcBAwe_gmAxhQUSg3CjeBnb1JtY1JK6ZhEjuwHoT0KSMDQodgxXJAYjkgsXdmHiE5XoAZBBNhkjsQOO1Z_gYKNsuR</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Ilzarbe, Lidia</creator><creator>Ilzarbe, Daniel</creator><creator>Gutiérrez-Arango, Felipe</creator><creator>Baeza, Inmaculada</creator><general>Bentham Science Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230101</creationdate><title>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</title><author>Ilzarbe, Lidia ; Ilzarbe, Daniel ; Gutiérrez-Arango, Felipe ; Baeza, Inmaculada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Child</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine, Neurology, Pharmacology, Neuroscience</topic><topic>Olanzapine</topic><topic>Prolactin</topic><topic>Risperidone - therapeutic use</topic><topic>Sex Characteristics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ilzarbe, Lidia</creatorcontrib><creatorcontrib>Ilzarbe, Daniel</creatorcontrib><creatorcontrib>Gutiérrez-Arango, Felipe</creatorcontrib><creatorcontrib>Baeza, Inmaculada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ilzarbe, Lidia</au><au>Ilzarbe, Daniel</au><au>Gutiérrez-Arango, Felipe</au><au>Baeza, Inmaculada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis</atitle><jtitle>Current neuropharmacology</jtitle><addtitle>CN</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>21</volume><issue>6</issue><spage>1319</spage><epage>1328</epage><pages>1319-1328</pages><issn>1570-159X</issn><eissn>1875-6190</eissn><abstract>Background: Serum prolactin levels are influenced by sex, physical development and medications among other factors. Antipsychotics usually increase serum prolactin levels in both adults and younger patients, but no study has reviewed the potential association between sex and vulnerability for developing hyperprolactinemia among children and adolescents. Objective: Systematic review and meta-analysis of serum prolactin levels in children and adolescents on antipsychotic treatment for any psychiatric diagnosis to determine the effect of sex. Methods: A systematic search was performed in MEDLINE/PubMed/Web of Science and Cochrane databases for randomized controlled trials of antipsychotics in children and adolescents reporting serum prolactin levels by sex. Results: Of 1278 identified records, seven studies were included, comparing different single antipsychotics to placebo (risperidone N=4; lurasidone N=1; olanzapine N=1; queriapine N=1). Both male and female children and adolescents on antipsychotics presented a significant increase in prolactin levels relative to subjects receiving a placebo. (Male: 16.53 with 95% CI: 6.15-26.92; Female: 26.97 with 95% CI: 9.18-44.75). The four studies using risperidone had similar findings (Male: 26.49 with 95% CI: 17.55-35.43; Female: 37.72 with 95% CI: 9.41-66.03). In the direct comparison between sexes, females showed greater increases in prolactin, but the differences were not statistically significant. Conclusion: Serum prolactin levels are increased in children and adolescents of both sexes on antipsychotics, with females showing a slightly greater increase than males. Further research is needed to clarify the influence of sex and pubertal status on prolactin levels in children and adolescents taking antipsychotics.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers</pub><pmid>36305138</pmid><doi>10.2174/1570159X21666221027143920</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1570-159X
ispartof Current neuropharmacology, 2023-01, Vol.21 (6), p.1319-1328
issn 1570-159X
1875-6190
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10324329
source PubMed Central
subjects Adolescent
Adult
Antipsychotic Agents - therapeutic use
Child
Female
Humans
Male
Medicine, Neurology, Pharmacology, Neuroscience
Olanzapine
Prolactin
Risperidone - therapeutic use
Sex Characteristics
title Sex Differences in Serum Prolactin Levels in Children and Adolescents on Antipsychotics: A Systematic Review and Meta-Analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A52%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sex%20Differences%20in%20Serum%20Prolactin%20Levels%20in%20Children%20and%20Adolescents%20on%20Antipsychotics:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Current%20neuropharmacology&rft.au=Ilzarbe,%20Lidia&rft.date=2023-01-01&rft.volume=21&rft.issue=6&rft.spage=1319&rft.epage=1328&rft.pages=1319-1328&rft.issn=1570-159X&rft.eissn=1875-6190&rft_id=info:doi/10.2174/1570159X21666221027143920&rft_dat=%3Cproquest_pubme%3E2730319906%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b494t-8b25f94a4ab59c1a571926b07494cb63211cce465c9551d199967889fc70de6f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2730319906&rft_id=info:pmid/36305138&rfr_iscdi=true